new_0222_0261|PHAT|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0261|PHAT|1|Phathom Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Phathom Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Phathom Pharmaceuticals Inc Inventories (Quarterly) (USD)|Phathom Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Phathom Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Phathom Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Phathom Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Phathom Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Phathom Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Phathom Pharmaceuticals Inc Book Value (Quarterly) (USD)|Phathom Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Phathom Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Phathom Pharmaceuticals Inc EV to Revenues|Phathom Pharmaceuticals Inc EV to Earnings|Phathom Pharmaceuticals Inc EV to Free Cash Flow|Phathom Pharmaceuticals Inc EV to Assets (Quarterly)|Phathom Pharmaceuticals Inc PS Ratio|Phathom Pharmaceuticals Inc PE Ratio|Phathom Pharmaceuticals Inc Price to Book Value|Phathom Pharmaceuticals Inc PEG Ratio|Phathom Pharmaceuticals Inc Debt to Equity Ratio|Phathom Pharmaceuticals Inc Dividend Yield|Phathom Pharmaceuticals Inc Shareholder Yield (TTM)|Phathom Pharmaceuticals Inc Percent of Shares Outstanding Short|Phathom Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Phathom Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Phathom Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Phathom Pharmaceuticals Inc Return on Invested Capital|Phathom Pharmaceuticals Inc Quality Ratio Score|Phathom Pharmaceuticals Inc Momentum Score|Phathom Pharmaceuticals Inc Beta (1Y)|Phathom Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Phathom Pharmaceuticals Inc Institutional Investor Ownership Percentage|Phathom Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Phathom Pharmaceuticals Inc Total Employees (Annual)|Phathom Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Phathom Pharmaceuticals Inc Shares Outstanding|Phathom Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Phathom Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Phathom Pharmaceuticals Inc Payout Ratio|Phathom Pharmaceuticals Inc Quick Ratio (Quarterly)|Phathom Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Phathom Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Phathom Pharmaceuticals Inc Effective Tax Rate (TTM)|Phathom Pharmaceuticals Inc Return on Equity|Phathom Pharmaceuticals Inc Net Income (TTM) (USD)|Phathom Pharmaceuticals Inc Revenue (TTM) (USD)|Phathom Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Phathom Pharmaceuticals Inc Revenue (Quarterly) (USD)|Phathom Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Phathom Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Phathom Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Phathom Pharmaceuticals Inc Net Income (Quarterly) (USD)|Phathom Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Phathom Pharmaceuticals Inc Price (USD)|Phathom Pharmaceuticals Inc Total Return Price (USD)|Phathom Pharmaceuticals Inc Enterprise Value (USD)|Phathom Pharmaceuticals Inc 30-Day Average Daily Volume|Phathom Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_0222_0261|PHAT|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0261|PHAT|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0261|PHAT|5|100.4|100.4||100.4||100.4|100.4|100.4||100.4|100.4||||1.44795539033||||1.44712430427|||1.45111492281||15.2407407407|104.428571429|100.4|100.4|||32.8461538462|30.4666666667|||91.3333333333|229|91.3333333333|33.7272727273|92|100.4|||91.3333333333|92|||91.4444444444|||||91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.45034246575|1.45034246575|1.45111492281|1.45126353791|1.44712990937||
new_0222_0261|PHAT|6|10|10||10||10|10|10||10|10||||538||||539|||583||54|7|10|10|||13|15|||12|2|12|22|1|10|||12|1|||9|||||12|12|12|12|584|584|583|554|331||
new_0222_0261|PHAT|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0261|PHAT|201809||||||||||||||||||||||||||||||||||8.5783||-0.0338||||||-0.0338|||||||||0.262|-0.29|-0.29|-0.004|||||||
new_0222_0261|PHAT|201812|0.902|0.879||||2.188|2.188|||-1.286|-1.288||||||||||||||0.019|0.055||||||||8.5783||-0.0564|||22.8903|||-0.0564|||||||||0.437|-0.484|-0.484|-0.005|||||||
new_0222_0261|PHAT|201903||||||||||||||||||||||||||||||||||8.5783||-0.1458||||||-0.1458|||||||||0.797|-1.251|-1.251|-0.011|||||||
new_0222_0261|PHAT|201906|84.542|82.917||||169.264|144.752|24.512||-84.385|-90.301|||||||||||||||0.45||||||||8.5783||-10.2307|||22.8903|||-10.081||||-89.787|||||1.345|-87.762|-87.762|-1.036|||||||
new_0222_0261|PHAT|201909|77.653|74.484||0.04||232.167|207.493|24.674||-152.461|-158.413|||||||||||||0.0189||0.439||||||||22.8903|16|-2.9756|24.7458|-1.299|22.8903|||-0.4515|1.299|||-157.609|||||1.813|-68.112|-68.112|-1.561|23.62|23.62|627.8518|||25.6|
new_0222_0261|PHAT|201912|255.601|243.765||1.396||29.223|3.748|25.475||227.955|-256.419||||-15.0384||||3.378|||||2.8673||0.699|0.002|||||||24.7283|25|-3.9633|24.7283|1.299|24.7283|||-2.4585|-192.771|||-255.131|||||2.989|-98.006|-98.006|-0.48|31.14|31.14|549.0513|187297.5||33.37|36.12
new_0222_0261|PHAT|202003|261.827|256.672||1.707||55.22|4.576|50.644||208.695|-276.56||||-6.0059||||3.112|||||3.2888||1.187|0.002|||||||32.4704||-0.62|25.1536||25.1536|||-0.6229||||-274.021|||||4.51|-20.141|-20.141|0.14|25.82|25.82|438.707|80042.1333||33.84|42.28
new_0222_0261|PHAT|202006|248.679|247.271||3.362||63.999|13.258|50.741||188.423|-297.661||||-12.3174||||4.4738|||||4.8642||4.894|0.003|||||||32.9971||-0.64|25.6144||25.6144|||-0.64||||-207.36|||||5.162|-21.101|-21.101|-1.08|32.91|32.91|641.9579|125429.5667||33.26|36.76
new_0222_0261|PHAT|202009|227.161|226.361||3.347||74.501|27.67|46.831||156.388|-331.766||||-11.6945||||6.0768|||||3.1556||4.788|0.003|||9|1.6076|||33.3662||-1.02|25.9161||25.9161|||-1.02||||-173.353|||||7.06|-34.105|-34.105|-1.271|36.67|36.67|770.6004|43915.0667|69.6552|39.36|42.82
new_0222_0261|PHAT|202012|291.368|287.496||3.359||100.84|55.524|45.316||194.271|-385.487||||-9.9931||||4.8762|||||2.8383|0.082|16.782|0.003|||9|1.275|||34.0742|55|-1.58|28.516||28.516|||-1.58||||-129.068|||||10.785|-53.721|-53.721|-1.279|33.22|33.22|706.7925|180979.7667|6.6795|38.5|44.05
new_0222_0261|PHAT|202103|242.81|237.974||3.168||82.024|40.845|41.179||164.339|-420.33||||-8.2342||||6.5998|||||1.967||10.857|0.003|||5|1.0621|||36.299||-0.96|28.8765||28.8765|||-0.96||||-143.77|||||13.004|-34.843|-34.843|-1.258|37.56|37.56|893.9793|105314.2333|45.4686|38.52|35.35
new_0222_0261|PHAT|202106|211.338|209.669||2.95||82.451|39.611|42.84||132.128|-456.882||||-6.4743||||7.4772|||||4.2288||5.401|0.003|||2|-0.008|||36.6362||-1|29.1862||29.1862|||-1||||-159.221|||||13.722|-36.552|-36.552|-1.243|33.85|33.85|825.9689|124284|2.8563|32.1|35.59
new_0222_0261|PHAT|202109|225.313|224.618||2.723||124.896|27.811|97.085||103.481|-493.544||||-6.1011||||9.3208|||||5.0339||5.582|0.003|||3|0.1399|||37.2994||-0.98|30.0474||30.0474|||-0.98||||-161.778|||||16.529|-36.662|-36.662|-1.477|32.1|32.1|828.2085|80984.2|-12.4625|23.53|17.94
new_0222_0261|PHAT|202112|||||||||||||||-3.581||||6.0149|||||13.9416||||||2|-0.1662||||||||||||||||||||||||19.67|19.67|486.1146|134767|-40.7887|16.8|17.98